Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency

Biomaterials

Volumn 33, Issue 7, 2012, Pages 2321-2326

  Rahmat, Deni ^a   Khan, Mohammad I ^b   Shahnaz, Gul ^a   Sakloetsakun, Duangkamon ^c   Perera, Glen ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Gene delivery; Nanoparticles; Tat peptide; Thioglycolic acid; Transfection

Indexed keywords

CELL LINES; CELL-PENETRATING PEPTIDE; COMPLEX COACERVATION; GENE DELIVERY; GENE DELIVERY SYSTEMS; GREEN FLUORESCENT PROTEIN; HEK293 CELLS; MODIFIED CHITOSAN; NONVIRAL; PLASMID DNA (PDNA); REPORTER GENE; SIZE RANGES; SYNERGISTIC EFFECT; TAT PEPTIDE; THIOGLYCOLIC ACID; THIOMERS; TRANSFECTION; TRANSFECTION EFFICIENCY; ZETA POTENTIAL MEASUREMENTS;

CELL CULTURE; CELLS; EFFICIENCY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GENE THERAPY; GENE TRANSFER; MOLECULAR BIOLOGY; MULTILAYERS; NANOPARTICLES; PEPTIDES; ZETA POTENTIAL;

CHITOSAN;

CELL PENETRATING PEPTIDE; CHITOSAN; GREEN FLUORESCENT PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; NANOCONJUGATE; PLASMID DNA; THIOGLYCOLIC ACID; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL STRAIN HEK293; CELL VIABILITY; CHEMICAL STRUCTURE; CYTOTOXICITY TEST; EMBRYO; FLUORESCENCE MICROSCOPY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INCUBATION TIME; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN PURIFICATION; REPORTER GENE; ZETA POTENTIAL;

CELL-PENETRATING PEPTIDES; CHITOSAN; DNA; DRUG SYNERGISM; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HUMANS; MATERIALS TESTING; MOLECULAR STRUCTURE; NANOPARTICLES; SULFHYDRYL COMPOUNDS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84855742762     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.11.046     Document Type: Article

References (21)

1. Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., Fernandes J.C. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm 2004, 57:1-8.
2. Martien R., Loretz B., Sandbichler A.M., Bernkop-Schnürch A. Thiolated chitosan nanoparticles: transfection study in the Caco-2 differentiated cell culture. Nanotechnology 2008, 19:1-9.
3. Lee D., Zhang W., Hellermann G.R., Shirley S.A., Lockey R.F., Kong X., et al. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res 2007, 24:157-167.
4. Schmitz T., Bravo-Osuna I., Vauthier C., Ponchel G., Loretz B., Bernkop-Schnürch A. Development and invitro evaluation of a thiomer-based nanoparticulate gene delivery system. Biomaterial 2007, 28:524-531.
5. Silhol M., Tyagi M., Giacca M., Lebleu B., Vives E. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem 2002, 269:494-501.
6. Howl J., Nicholl I.D., Jones S. The many futures for cell-penetrating peptides: how soon is now?. Biochem Soc Trans 2007, 35:767-769.
7. Schwarze S.R., Hruska K.A., Dowdy S.F. Protein transduction: unrestricted delivery into cells?. Trends Cell Biol 2000, 10:290-295.
8. Bernkop-Schnürch A., Scholler S., Biebel R.G. Development of controlled drug release systems based on thiolated polymers. JControl Release 2000, 66:39-48.
9. Liu L., Venkatraman S.S., Yang Y.Y., Guo K., Moochhala S., Kann L. Polymeric micelles anchored with Tat for delivery of antibiotics across the blood-brain barrier. Pep Sci 2008, 90:617-623.
10. Kafedjiiski K., Föger F., Werle M., Bernkop-Schnürch A. Synthesis and invitro evaluation of a novel chitosan-glutathione conjugate. Pharm Res 2005, 22:1480-1488.
11. Corsi K., Chellat F., Yahia L.H., Fernandes J.C. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterial 2002, 24:1255-1264.
12. Desai M.P., Amidon G.L. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996, 13:1838-1845.
13. Whitely N.M., Berg H.C. Amidination of the outer and inner surfaces of the human erthrocytes membrane. JMol Biol 1974, 87:541-561.
14. Patel N., Davies M.C., Hartshorne M., Heaton R.J., Roberts C.J., Williams P.M., et al. Immobilization of protein molecules onto homogeneous and mixed carboxylate terminated self-assembled monolayers. Langmuir 1997, 13:6485-6490.
15. Staros J.V., Wright R.W., Swingle D.M. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reaction. Anal Biochem 1986, 156:220-222.
16. Mislick K.A., Baldeschwieler J.D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci USA 1996, 93:12349-12354.
17. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Del Rev 2003, 55:329-347.
18. Hoekstra D., Rejman J., Wasungu L., Shi F., Zuhorn I. Gene delivery by cationic lipids: in and out of an endosome. Biochem Soc Trans 2007, 35:68-71.
19. Leroueil P.R., Hong S., Mecke A., Baker J.R., Orr B.G., Holl M.M.B. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?. Acc Chem Res 2007, 40:335-342.
20. Ziegler A., Seelig J. Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters. Biophys J 2004, 86:254-263.
21. Tamura M., Natori K., Kobayashi M., Miyamura T., Takeda N. Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane. JVirol 2004, 78:3817-3826.